Breaking News on Global Pharmaceutical Technology & Manufacturing

Colorcon building film facility in Brazil to cater for growing pharma market

04-May-2016 - Colorcon is building a film coating production facility in Indaiatuba, Brazil to service markets in South America.

Biogen haemophilia spin-out to develop gene therapies and long-acting factors

04-May-2016 - The new entity will focus on a haemophilia pipeline utilising the XTEN half-life extension technology, bispecific antibodies and gene therapies.

French regulators lift manufacturing ban at Catalent softgel plant

02-May-2016 - Full production at Catalent’s Beinheim softgel plant has begun five months after the discovery of out-of-place capsules led to French regulators suspending operations.

Aptar launches sensor counter tech for MDIs

28-Apr-2016 - Aptar Pharma has launched a new counter technology for metered dose inhalers (MDIs) it says can help enhance patient adherence.

George Freeman: New meds and delivery methods a regulatory challenge

26-Apr-2016 -   [View the story "Live from #Biotrinity2016" on Storify]

GSK's Ware Ellipta plant to supply US after Zebulon line operational

25-Apr-2016 - GSK has confirmed its new UK plant will continue to supply the US with Ellipta inhalers after capacity at its facility in North Carolina comes online this year.

GSK opens £56m Ellipta inhaler plant in the UK

21-Apr-2016 - GSK has doubled production capacity for its Ellipta dry powder inhaler (DPI) with a new UK manufacturing plant UK. 

BioCellChallenge granted US patent for antibody delivery tech

20-Apr-2016 - Triazamacrocyclic lipid complexes increase the efficiency of antibody-drug conjugates (ADCs) by delivering the payload right into the heart of a cancer cell, says BioCellChallenge.

Building a better biomedical knowledgebase

18-Apr-2016 - Researchers as The Scripps Research Institute (TSRI) are working to create a public database where researchers can easily access biomedical knowledge.

Lonza would add drug delivery tech through Catalent merger, analyst

14-Apr-2016 - Lonza acquiring Catalent would make “strategic sense,” according to an analyst as rumours circulate about a CMO megamerger.

Colorcon launches new coating for multiparticulate pills

13-Apr-2016 - Colorcon has launched a tablet coating system for multiparticulate dosage forms citing growing demand for such pills, particularly among the elderly.

Oasmia looking to license Vitamin A-derived drug delivery tech

12-Apr-2016 - Oasmia Pharmaceutical has announced clinical results for its XR17 nanotechnology it says validates the excipient as a potential drug delivery system.

Pill attaches to GI tract lining for slow release

11-Apr-2016 - Researchers have developed a new tablet that attaches to the lining of the GI tract and slowly releases medication.

MannKind waves 'au revoir' to Sanofi as it regains Afrezza rights

06-Apr-2016 - The rights to inhaled insulin drug Afrezza have returned to Mannkind Corporation, three months after Sanofi terminated its commercialisation deal.

Catalent: Limited production begins at suspended French softgel plant

04-Apr-2016 - Catalent has missed its forecast for bringing a suspended softgel facility back online, but says production of essential drugs has begun at the French plant.

AC/DC's "Thunderstruck" key to new drug particle coating technique

01-Apr-2016 - Researchers in Australia are using a song by rock band AC/DC in a new coating process that they claim improves API delivery characteristics. 

Capsugel ripe to be sold or go public, investment banker

30-Mar-2016 - Rumours Capsugel owner KKR is mulling a sale or an IPO fit with the typical private equity investment cycles says expert.

First 3D printed medicine now available

29-Mar-2016 - The drug, manufactured by Aprecia Pharmaceuticals, is the first 3D printed prescription drug to receive US FDA approval.

Blu buy bolsters Puracap in US softgel market

29-Mar-2016 - Puracap has bought Blu Pharmaceuticals and its Puerto Rican manufacturing site and plans to double oral dose production capacity.

Sanofi goes to High Court over Indian ban on fixed dose combo diabetes drug

24-Mar-2016 - Sanofi has challenged an Indian Government decision banning the manufacture and sale of its fixed dose combination diabetes drug, Amaryl MP.

Meringue? No, you're not wrong: TxCell outlines unusual Ovasave delivery method

22-Mar-2016 - TxCell is working on new ways of delivering its Crohn's disease therapy Ovasave that will replace the somewhat unusual method it is using in clinical trials.

Braeburn plans $20m NC plant; awaits FDA decision on subdermal buprenorphine

22-Mar-2016 - Braeburn Pharmaceuticals will establish an R&D and manufacturing site in North Carolina for its subdermal implant candidate to treat opioid addiction.

CSL Behring using Albumedix tech to extend the half-life of new haemophilia drug

21-Mar-2016 - CSL Behring has opted to extend the half-life of its haemophilia B treatment Idelvion using a technology developed by Novozymes A/S subsidiary Albumedix.

Hikma: Ben Venue tech transfer and network investments to boost injectables biz

17-Mar-2016 - Hikma says the $82m pumped into its injectables network last year will be a factor in returning the sector to growth in 2016.

Plant-based vaccines poised to challenge $4bn seasonal flu shot market

14-Mar-2016 - An influenza vaccine produced in tobacco plants could make a big impact in the market if it reaches the market in the US in time for the 2018-19 flu season, says a market analyst.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...